Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$125.57 n/a | n/a%
01/23/15 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -687.55M -51.14M 41.18M -754.63M
Operating Gains/Losses 0.00 390.00K 16.86M 41.27M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 53.36M 39.91M -170.61M -2.92M
(Increase) Decrease in Inventories 7.14M -29.92M -111.39M 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -49.23M 14.89M 37.47M -1.18M
(Decrease) Increase In Other Current Liabilities 48.75M 17.87M 125.62M 6.79M
(Increase) Decrease In Other Working Capital -53.01M -44.28M -72.44M -65.86M
Other Non-Cash Items 877.72M 257.52M 232.82M 97.64M
Net Cash From Continuing Operations -51.57M 267.84M 143.74M -635.44M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -51.57M 267.84M 143.74M -635.44M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 2.35B 1.37B 1.02B 1.28B
Purchases of Property, Plant & Equipment -51.39M -71.14M -94.60M -38.05M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -2.41B -1.71B -721.54M -1.23B
Other Cash from Investing Activities 61.39M -16.78M 12.51M -4.73M
Cash Provided by Financing Activities
Net Cash From Investing Activities -54.13M -425.82M 212.41M 7.30M
Issuance of Debt 0.00 0.00 0.00 391.64M
Cash Used for Financing Activities
Issuance of Capital Stock 265.88M 191.72M 124.86M 33.43M
Repayment of Long-Term Debt -83.74M -21.49M -250.00M -22.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -1.25M 1.97M 900.00K 0.00
Net Cash From Financing Activities 180.88M 172.20M -124.24M 425.06M
Effect of Exchange Rate Changes 4.71M -141.00K 214.00K -377.00K
Net Change in Cash & Cash Equivalents 79.89M 14.09M 232.12M -203.46M

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter